Search Within

Hematology-Oncology Fellows

  1. "James Smithy"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (7)
  3. Editorial (5)
  4. Review (4)
  5. Research Letter (1)
Groups
  1. GME, Medicine (28)
  2. Graduate Medical Education (28)
  3. Melanoma Disease Management Team (28)
  4. Weinberg Fellows (28)
  5. Department of Medicine (23)
  6. Solid Tumor Oncology Division (23)

More Groups

People
  1. James Smithy (28)
  2. Michael Postow (17)
  3. Alexander Shoushtari (12)
  4. Katherine Panageas (11)
  5. Parisa Momtaz (8)
  6. Allison Betof Warner (6)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (2)
Publications
  1. Journal of Clinical Oncology (9)
  2. Annals of Oncology (4)
  3. Clinical Cancer Research (3)
  4. Cancer Cell (1)
  5. Cancer Discovery (1)
  6. Cell Reports (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (4)
  3. Oxford University Press (4)
  4. Cell Press (2)
  5. Lippincott Williams & Wilkins (2)
  6. Wiley Blackwell (2)

More Publishers

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quantitatively defined stromal B cell aggregates are associated with response to checkpoint inhibitors in unresectable melanoma
    Journal Article

    Smithy, J. W.; Peng, X.; Ehrich, F. D.; Moy, A. P.; Yosofvand, M.; Maher, C.; Aleynick, N.; Vanguri, R.; Zhuang, M.; Lee, J.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • The clinical TIL experience in melanoma: Past, present, future
    Review

    Smithy, J. W.; Schoenfeld, A. J.; Betof Warner, A.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor rechallenge after treatment with tumor-infiltrating lymphocytes in unresectable melanoma
    Meeting Abstract

    Betof Warner, A.; Smithy, J. W.; Los, C.; Kalvin, H.; Hasson, N.; Amaria, R. N.; Andrade Czapla, J. A.; Schollenberger, M.; furness, A.; Hassel, J. C.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • NivoLag-when: International real-world study of combination immunotherapy sequences in melanoma
    Meeting Abstract

    Guardamagna, M.; Marqueste, C. G.; Malissen, N.; Roy, S.; da Silva, I. P.; Long, G. V.; Smithy, J. W.; Postow, M. A.; Dimitriou, F.; Dummer, R.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • HERTHENA-PanTumor01: A global phase II trial of HER3-DXd in metastatic solid tumors
    Meeting Abstract

    Powles, T. B.; Bhatia, A. K.; Burtness, B.; Kogawa, T.; Nishina, T.; Nakayama, I.; Fountzilas, C.; Castillo, D. R.; McKean, M.; Meric-Bernstam, F.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Intratumoral vidutolimod in combination with PD-1 blockade in locoregionally advanced melanoma
    Editorial

    Smithy, J. W.; Postow, M. A.
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
    Journal Article

    Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; Lamberti, G.; Gandhi, M. M.; Vaz, V. R.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Warner, A. B.; Smithy, J. W.; Postow, M. A.; Panageas, K.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save